1 of 1
Story summary
- Karnataka Health Minister U.T. Khader welcomed the National Pharmaceutical Pricing Authority’s (NPPA) approval to cap anti-cancer margins at 30%.
- NPPA gave in-principle approval on October 8, pending the final medicine list.
- Karnataka asked the Centre to extend the 30% cap to cardiac and kidney drugs.
- The Centre estimates 20-70% price cuts could save patients about INR2,500 crore.
- A notice on October 1 directs hospitals to list cost and MRP on bills from November 1.